Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2012 Jan 16;18(8):1211–1218. doi: 10.1016/j.bbmt.2012.01.009

Figure 2.

Figure 2

Non-relapse mortality following HCT according to pre-transplant therapy: azacitidine (AZA) vs. induction chemotherapy (IC). Patients were censored at the last follow up. The difference between AZA and IC was not significant at p = 0.98.